ProPhase Labs Inc  

(Public, NASDAQ:PRPH)   Watch this stock  
Find more results for PRPH
2.27
+0.02 (0.89%)
Sep 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.26 - 2.27
52 week 1.78 - 2.45
Open 2.26
Vol / Avg. 7,561.00/19,472.00
Mkt cap 36.70M
P/E 2.70
Div/yield     -
EPS 0.84
Shares 16.17M
Beta 0.08
Inst. own 22%

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -76.64% -13.65%
Operating margin -84.57% -12.64%
EBITD margin - -10.61%
Return on average assets -10.88% -20.76%
Return on average equity -12.04% -38.78%
Employees 54 -
CDP Score - -

Address

621 N Shady Retreat Rd
DOYLESTOWN, PA 18901-2514
United States - Map
+1-215-3450919 (Phone)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.

Officers and directors

Ted William Karkus Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Robert V. Cuddihy Jr. Chief Financial Officer, Chief Operating Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Jason M. Barr Director
Age: 37
Bio & Compensation  - Reuters
Mark A. Burnett Independent Director
Age: 57
Bio & Compensation  - Reuters
Louis Gleckel M.D. Independent Director
Age: 61
Bio & Compensation  - Reuters
James T. McCubbin Independent Director
Age: 52
Bio & Compensation  - Reuters